|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 118.15 INR | -1.99% |
|
-4.95% | +64.35% |
| May. 21 | Dubai Investments says Globalpharma signs 7 strategic MoUs | RE |
| May. 20 | ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026 |
| Market Cap | 6.33B 66.33M 58.09M 53.5M 49.66M 94.31M 95.58M 640M 249M 3.11B 249M 244M 10.77B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 7.19B 75.38M 66.01M 60.8M 56.44M 107M 109M 728M 283M 3.53B 283M 277M 12.24B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.65% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: ZIM Laboratories Limited
| 1 day | -1.99% | ||
| 1 week | -4.95% | ||
| Current month | -4.95% | ||
| 1 month | +14.21% | ||
| 3 months | +72.28% | ||
| 6 months | +68.74% | ||
| Current year | +64.35% |
| 1 week | 118.15 | 125 | |
| 1 month | 103.45 | 133.95 | |
| Current year | 59.72 | 133.95 | |
| 1 year | 59.72 | 133.95 | |
| 3 years | 59.72 | 151.75 | |
| 5 years | 36.37 | 151.75 | |
| 10 years | 14 | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 2001-12-31 |
| Director of Finance/CFO | - | 2019-03-31 | |
| Director of Finance/CFO | - | 1990-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 1989-12-31 |
| Director/Board Member | - | 1990-12-31 | |
Prakash Sapkal
BRD | Director/Board Member | - | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.99% | -4.95% | +6.63% | +11.67% | 67.67M | ||
| -0.49% | +2.20% | +13.30% | +83.78% | 48.11B | ||
| -1.41% | +6.57% | +71.07% | +120.76% | 37.88B | ||
| -1.39% | -0.93% | -3.89% | +42.24% | 12.47B | ||
| +0.44% | +3.63% | +15.44% | +98.02% | 12B | ||
| +1.82% | +2.76% | +34.19% | +120.25% | 9.03B | ||
| 0.00% | +2.07% | +22.51% | +48.19% | 7.24B | ||
| +0.41% | +2.95% | +56.10% | -2.71% | 7.09B | ||
| -0.62% | +21.06% | -16.02% | +24.43% | 6.54B | ||
| -0.26% | +2.75% | +21.76% | +228.60% | 6.72B | ||
| Average | -0.36% | +4.46% | +22.11% | +77.53% | 14.71B | |
| Weighted average by Cap. | -0.52% | +4.49% | +29.77% | +91.21% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.75M 34.81M 32.06M 29.76M 56.51M 57.28M 384M 149M 1.86B 149M 146M 6.45B | 3.74B 39.25M 34.38M 31.66M 29.39M 55.81M 56.56M 379M 147M 1.84B 147M 144M 6.37B |
| Net income | 122M 1.28M 1.12M 1.03M 955K 1.81M 1.84M 12.31M 4.79M 59.71M 4.79M 4.68M 207M | 58.38M 612K 536K 494K 458K 870K 882K 5.91M 2.3M 28.66M 2.3M 2.25M 99.36M |
| Net Debt | 1.16B 12.14M 10.63M 9.79M 9.09M 17.26M 17.49M 117M 45.61M 568M 45.58M 44.58M 1.97B | 863M 9.05M 7.92M 7.3M 6.77M 12.87M 13.04M 87.37M 34M 424M 33.98M 33.23M 1.47B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | ₹118.15 | -1.99% | 857 |
| 26-07-06 | ₹120.55 | -1.99% | 732 |
| 26-07-03 | ₹123.00 | -0.08% | 2,591 |
| 26-07-02 | ₹123.10 | -1.52% | 3,718 |
| 26-07-01 | ₹125.00 | +0.56% | 8,541 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















